CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
OPERATING EXPENSES
General and administrative (net of insurance reimbursement of $0 and $1,250,000 during the three and nine months ended September 30, 2023 - See Note 5)	$ 780,958	$ 4,619,519	$ 3,972,428	$ 6,983,670
Research and development	1,143,396	1,495,619	4,712,765	4,022,020
Total operating expenses	1,924,354	6,115,138	8,685,193	11,005,690
Loss from operations	(1,924,354)	(6,115,138)	(8,685,193)	(11,005,690)
OTHER INCOME (EXPENSE)
Interest expense	(92,748)	0	(103,750)	0
Other income	10,646	120,640	111,806	377,891
Total other income (expense)	(82,102)	120,640	8,056	377,891
Net loss	$ (2,006,456)	$ (5,994,498)	$ (8,677,137)	$ (10,627,799)
Basic net loss per share	$ (0.43)	$ (5.12)	$ (3.34)	$ (9.07)
Diluted net loss per share	$ (0.43)	$ (5.12)	$ (3.34)	$ (9.07)
Basic weighted average common stock outstanding	4,657,711	1,171,233	2,594,504	1,171,233
Diluted weighted average common stock outstanding	4,657,711	1,171,233	2,594,504	1,171,233